Previous Article | Next Article 
Infect Immun, April 1998, p. 1787-1790, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Human Intestinal Epithelial Cells Respond to
Cryptosporidium parvum Infection with Increased
Prostaglandin H Synthase 2 Expression and Prostaglandin E2
and F2
Production
Fabrice
Laurent,1
Martin F.
Kagnoff,1
Tor C.
Savidge,2,
Muriel
Naciri,3 and
Lars
Eckmann1,*
Laboratory of Mucosal Immunology, Department
of Medicine, University of California, San Diego, La Jolla,
California 920931;
Department of
Cellular Physiology, The Babraham Institute, Babraham, Cambridge CB2
4AT, United Kingdom2; and
Laboratoire de Protozoologie, Centre INRA de Tours, 37380 Nouzilly, France3
Received 7 October 1997/Returned for modification 6 November
1997/Accepted 14 January 1998
 |
ABSTRACT |
Cryptosporidium parvum is an important cause of
diarrhea in humans and several animal species. Prostaglandins play a
central role in regulating intestinal fluid secretion in animal models of cryptosporidiosis, but their cellular sources and mechanisms of
induction are unclear. Here, we show that C. parvum
infection directly activates prostaglandin H synthase 2 expression and
prostaglandin E2 and F2
production in human
intestinal epithelial cells.
 |
TEXT |
Cryptosporidium parvum is
an important cause of diarrhea in both immunocompetent and
immunosuppressed hosts and is responsible for 1 to 2% of deaths in
patients with acquired immunodeficiency syndrome (21). The
mechanisms underlying C. parvum-induced diarrhea in humans
are poorly understood. The presence of an enterotoxic activity released
by the parasite has been previously reported (8), but these
findings are controversial (20). In a porcine model of
cryptosporidiosis, diarrhea results from a combination of secretory
diarrhea and sodium-glucose malabsorption due to villous atrophy and
epithelial cell damage (3). The former is controlled by
prostaglandin E2 (PGE2) and prostacyclin
(PGI2), which appear to act either directly on intestinal
epithelial cell functions or indirectly by activating cholinergic and
VIPergic neuronal pathways (1). However, neither the
cellular source of PGE2 and PGI2 in this model,
nor the mechanisms leading to their induction are known. Inflammatory
cells in the mucosa, such as macrophages, can produce high levels of
prostaglandins and may be important for prostaglandin production after
C. parvum infection, since infection is often accompanied by
some degree of inflammation (7, 17). However, significant
diarrhea associated with C. parvum infection has been
reported in the absence of overt histopathological changes in the gut
(14, 18), suggesting that cells normally present in the
uninfected mucosa, e.g., epithelial cells or fibroblasts, produce
increased prostaglandin levels after infection. Our previous studies
suggested that intestinal epithelial cells, which are the predominant
host cells infected with C. parvum (15), can act
as sensors of infection and provide early signals for the initiation of
the mucosal inflammatory response by releasing chemoattractant
cytokines (12). Furthermore, other studies have shown that
infection of epithelial cells with invasive bacteria upregulates
prostaglandin production (5). Based on these findings, the
present studies tested the hypothesis that intestinal epithelial cells
respond to infection with C. parvum with increased
prostaglandin production.
C. parvum, which was initially isolated from an infected
child, was maintained in calves at the Institut National de la
Recherche Agronomique, Nouzilly, France, and C. parvum
oocysts were purified by filtration and diethyl ether sedimentation as
described previously (12). The human adenocarcinoma cell
lines HCT-8 (ATCC CCL 244) and HT-29 (ATCC HTB 38) were maintained in
RPMI 1640 medium-10% heat-inactivated fetal bovine serum (FBS)-2 mM
L-glutamine-50 U of penicillin G per ml-50 µg of
streptomycin per ml. Infections were performed as described previously
(12). Briefly, cells were seeded into six-well Costar tissue
culture plates at 2 × 106 cells/well and grown for
24 h. Infections with oocysts were done in a supplemented medium
as described by Upton et al. (24). After a 5-h infection
period, monolayers were washed, and fresh supplemented medium was
added. This time is referred to as 0 h for all experiments. To
determine the levels of prostaglandin production, cultures were washed
and incubated for 15 min in 1 ml of RPMI 1640 medium per well-10 mM
HEPES-2 mg of bovine serum albumin per ml-20 µM arachidonic acid.
Levels of the prostaglandins PGE2 and PGF2
were determined by enzyme immunoassay (Cayman Chemical, Ann Arbor,
Mich.). These prostaglandins were chosen for the present studies based
on our previous finding that they were the major prostaglandins
produced by human intestinal epithelial cell lines (5). To
correct for cell loss due to lysis of parasite-infected cells,
prostaglandin levels were divided for each culture by the amount of
total protein present in the culture at each time point (i.e., the time
of the assay). Total protein contents were determined by lysing the
monolayers in lysis buffer (150 mM NaCl, 20 mM Tris [pH 7.5], 0.1%
Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 µg of
aprotinin per ml) and by assaying the protein concentrations by the
Bradford method (Bio-Rad Laboratories, Hercules, Calif.). The lysates
were subsequently used for immunoblot analysis of prostaglandin H
synthase 1 (PGHS-1), PGHS-2, and actin expression by using previously
published protocols and antibodies (5). Levels of PGHS-2 and
-actin mRNA were determined by quantitative reverse transcription
(RT)-PCR with standard RNAs as we described before (5, 10).
The human intestinal xenograft model used in the present studies has
been described in detail before (12, 19). Briefly, human
fetal intestines were transplanted onto the backs of SCID mice and
allowed to develop for 10 to 15 weeks. At this time, a differentiated
epithelial layer of entirely human origin has developed
(19). Xenografts were infected by injecting 108
C. parvum oocysts in 200 µl of phosphate-buffered saline
(PBS) into the lumen. Control xenografts were injected with 200 µl of PBS (sham infection). Tissues were collected 5 days after infection, since this time point was shown in a rabbit intestinal xenograft model
to be the earliest after C. parvum infection at which there was consistent and widespread epithelial infection (23).
Successful infection was confirmed on paraffin sections stained with
hematoxylin and eosin and by transmission electron microscopy as
reported previously (12). Total RNA was extracted from
mucosal scrapings, and mRNA levels for PGHS-2 and
-actin and levels
of 28S rRNA were determined by quantitative RT-PCR (5). The
RT-PCR of PGHS-2 and
-actin was specific for the respective human
mRNAs, since amplification of mouse spleen RNA or DNA did not yield any
PCR products (5). The xenograft studies were performed at
the Babraham Institute, Cambridge, United Kingdom, with full approval
from the Cambridge Local Ethics Committee and in accordance with the Home Office guidelines specified in the Polkinghorne Report
(19).
Infection of HCT-8 cells with C. parvum increased
PGE2 production by as much as 50-fold (Fig.
1). The increase was first observed at
12 h after infection, was maximal by 36 h, and was sustained until the end of the observation period (72 h). Production of PGF2
also increased after C. parvum infection
with a kinetics similar to that of PGE2 production,
although the absolute levels produced and the relative increases after
infection were ~5-fold less than those for PGE2 (Fig. 1).
Similarly, C. parvum infection of another human intestinal
epithelial cell line, HT-29, increased PGE2 and
PGF2
production by >6-fold (controls, <30 pg of PGE2/mg of total protein and 9 ± 1 pg of
PGF2
/mg of protein; 36 h after C. parvum
infection, 204 ± 47 pg of PGE2/mg of protein and
171 ± 82 pg of PGF2
/mg of protein; values are
means ± standard errors of the means [SEM] of the results of
three independent experiments). In contrast to infection with live
C. parvum cells, exposure of HCT-8 cells to heat-inactivated
C. parvum (57°C for 1 h) did not affect
PGE2 or PGF2
production (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Time course of increased prostaglandin production after
C. parvum infection of HCT-8 cells. HCT-8 monolayers in
six-well plates were infected with 107 oocysts/well ( ),
of which 40 to 60% were found to excyst, as determined in parallel
experiments. Uninfected monolayers were used as a control ( ). The
amounts of PGE2 and PGF2 produced (A) were
determined after a 15-min incubation period with 20 µM arachidonic
acid at the indicated times after infection. Subsequently, monolayers
were lysed and the amounts of total protein/well were determined (B).
Data are means ± SEM of three to four independent experiments.
Asterisks, values that were significantly increased relative to those
in the respective uninfected controls (P 0.05), as
determined by the t test.
|
|
Prostaglandin production is controlled by the levels of the key enzyme
PGHS, which exists in two isoforms, PGHS-1 and PGHS-2. Although both
isoforms catalyze the same biosynthetic step, they display considerable
differences in regulation and tissue-specific expression and have
overlapping as well as unique physiologic functions (25).
Both isoforms are expressed in intestinal epithelial cells
(5). To define their role in the C. parvum-induced increase in PGE2 and
PGF2
production, two PGHS inhibitors were used, i.e.,
indomethacin and NS-398. Indomethacin, which inhibits both PGHS
isoforms, and NS-398, which is a highly specific inhibitor of PGHS-2
(6), completely blocked increased production of
PGE2 (Table 1) and
PGF2
(data not shown) after C. parvum
infection of HCT-8 cells. These data indicate that PGHS-2 was mostly
responsible for the increase in PGE2 and
PGF2
production after C. parvum infection. In
agreement with this, PGHS-2 levels increased after C. parvum
infection of HCT-8 cells (Fig. 2), with
time course and relative extent paralleling those of the increase in
PGE2 production (Fig. 1). In contrast, levels of PGHS-1
(Fig. 2) and actin were minimally affected by C. parvum
infection of HCT-8 cells (the ratios of the levels in infected relative
to control cells were 1.3, 1.3, and 0.8 for PGHS-1 at 24, 48, and
72 h after infection, respectively, and 1.3 and 0.8 for actin at
48 and 72 h after infection, respectively, as determined by
scanning densitometry of immunoblots). Furthermore, the increase in
PGHS-2 protein levels was paralleled by an increase in PGHS-2 mRNA
levels in C. parvum-infected HCT-8 cells (Fig.
3), although the relative increase in
PGHS-2 mRNA levels was less than that of PGHS-2 protein levels (Fig. 2).

View larger version (51K):
[in this window]
[in a new window]

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoblot analysis of PGHS-2 and PGHS-1 expression
after C. parvum infection of HCT-8 cells. HCT-8 monolayers
in six-well plates were infected with 107 C. parvum oocysts/well or were left uninfected (controls). Cultures
were incubated for the indicated periods of time, and cell lysates were
prepared, size fractionated, and blotted onto a nitrocellulose
membrane. PGHS-2 and PGHS-1 were detected with rabbit anti-human PGHS-2
and PGHS-1 (Oxford Biomedical), respectively, and the ECL system
(Amersham). (A) Examples of immunoblots for PGHS-2 and PGHS-1. Scans
were obtained with a Bio-Rad GS-670 scanning densitometer and
PhotoFinish imaging software. (B) Quantitative densitometric analysis
of the PGHS-2 immunoblot shown in panel A (continuous lines), along
with data from an additional experiment (dashed lines). PGHS-2 levels
were expressed as percentages of the maximum value observed for any of
the samples in each experiment (i.e., 36 h after C. parvum infection in both experiments). , C. parvum
infected; , uninfected controls.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Increased PGHS-2 mRNA expression in C. parvum-infected HCT-8 cells. HCT-8 monolayers in six-well plates
were infected with 107 oocysts. Levels of mRNAs for PGHS-2
( ) and -actin ( ) were determined by quantitative RT-PCR with
standard RNAs and were expressed as ratios of the values for infected
cells to those for controls. Data are the means ± SEM of the
results from three independent experiments. Mean mRNA levels in
controls were 2.2 × 105 transcripts/µg of total RNA
for PGHS-2 and 2.5 × 107 transcripts/µg of RNA for
-actin. Asterisks indicate that values are significantly increased
relative to those in the respective uninfected controls
(P 0.05), as determined by the t test.
|
|
To confirm the cell line findings in vivo, we used a human intestinal
xenograft model (19). This model has the advantage that
normal human intestinal epithelial cells can be infected with C. parvum under controlled conditions in the absence of potentially confounding coinfections, which are commonly encountered when samples
from C. parvum-infected patients are used. We showed
previously that the intestinal xenograft model can be successfully
infected with C. parvum and can be used to characterize
cytokine responses to infection (12). As shown in Table
2, levels of human PGHS-2 mRNA increased
by 10-fold when they were assayed 5 days after C. parvum
infection of intestinal xenografts. As a control, levels of 28S rRNA
and
-actin mRNA changed by <2-fold after infection. Intestinal
epithelial cells are the most abundant human cell type in the
xenografts (19) and are likely the only cells in this model
that become infected with C. parvum (12).
Moreover, the RT-PCR used in these studies is specific for human PGHS-2
mRNA (5). Together, these findings indicate that intestinal
epithelial cells most likely are responsible for the increase in PGHS-2
mRNA levels after C. parvum infection in the intestinal
xenograft model.
Intestinal epithelial cells respond to C. parvum infection,
as shown here, with increased PGHS-2 expression and PGE2
and PGF2
production. This epithelial response can
provide a partial explanation for the observation that PGHS products,
and PGE2 in particular, are important for regulating
increased fluid secretion in response to C. parvum
infection, as shown in piglets (2). Nonetheless, it is
difficult at present to assess the relative contributions of epithelial
cells and other cells, such as macrophages and subepithelial fibroblasts, to C. parvum-induced mucosal PGE2
production at different stages of the infection. In the normal
unstimulated state, epithelial PGE2 production represents
only a relatively small fraction of total mucosal PGE2
production in the rabbit colon (4, 13). However, based on
the present findings, the epithelial contribution appears to increase
substantially after infection. Regardless of the absolute amount of
PGE2 produced by intestinal epithelial cells after C. parvum infection, epithelial cell-derived PGE2 is
likely to be more efficient than PGE2 produced by cells in the underlying mucosa in affecting epithelial functions in a paracrine or autocrine manner, due to reduced diffusion distances. In contrast to
PGE2, epithelial production of PGF2
is
relatively high compared with total mucosal PGF2
production in the normal rabbit colon, even in the unstimulated state
(4, 13). However, PGF2
may be less important
than PGE2 in controlling epithelial ion transport, since it
was shown to be much less effective in inducing chloride secretion by
polarized human intestinal epithelial cell monolayers (5).
Increased epithelial PGHS-2 expression and PGE2 production
after C. parvum infection may have functions other than
regulating epithelial chloride and, concomitantly, fluid secretion. For
example, PGE2 upregulates epithelial mucin expression
(16). Increased mucus production is observed after C. parvum infection of suckling mice (9), which may be a
protective host response against further infection by the extracellular
stages of the parasite (22). PGE2 has also been
shown to downregulate inflammatory cytokine production by activated
macrophages (11), which could explain why, in some cases,
diarrhea can develop after C. parvum infection in the
apparent absence of mucosal inflammation.
 |
ACKNOWLEDGMENTS |
We thank Roselyne Mancassola for expert technical help.
This work was supported by National Institutes of Health grant DK35108,
a fellowship from the DRI of the Institut National de la Recherche
Agronomique, France (F.L.), and a Career Development award from the
Crohn's and Colitis Foundation of America (L.E.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
California, San Diego, Department of Medicine 0623D, 9500 Gilman Dr., La Jolla, CA 92093-0623. Phone: (619) 534 0683. Fax: (619) 534 5691. E-mail: leckmann{at}ucsd.edu.
Present address: Institute of Child Health, University of
Birmingham, Birmingham B16 8ET, United Kingdom.
Editor: J. M. Mansfield
 |
REFERENCES |
| 1.
|
Argenzio, R. A.,
M. Armstrong, and J. M. Rhoads.
1996.
Role of the enteric nervous system in piglet cryptosporidiosis.
J. Pharmacol. Exp. Ther.
279:1109-1115[Abstract/Free Full Text].
|
| 2.
|
Argenzio, R. A.,
J. Lecce, and D. W. Powell.
1993.
Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis.
Gastroenterology
104:440-447[Medline].
|
| 3.
|
Argenzio, R. A.,
J. A. Liacos,
M. L. Levy,
D. J. Meuten,
J. G. Lecce, and D. W. Powell.
1990.
Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs.
Gastroenterology
98:1129-1140[Medline].
|
| 4.
|
Craven, P. A., and F. R. DeRubertis.
1986.
Profiles of eicosanoid production by superficial and proliferative colonic epithelial cells and sub-epithelial colonic tissue.
Prostaglandins
32:387-399[Medline].
|
| 5.
|
Eckmann, L.,
W. F. Stenson,
T. C. Savidge,
D. C. Lowe,
K. E. Barrett,
J. Fierer,
J. R. Smith, and M. F. Kagnoff.
1997.
Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin H synthase-2 expression and prostaglandin E2 and F2 production.
J. Clin. Invest.
100:296-309[Medline].
|
| 6.
|
Futaki, N.,
S. Takahashi,
M. Yokoyama,
I. Arai,
S. Higuchi, and S. Otomo.
1994.
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.
Prostaglandins
47:55-59[Medline].
|
| 7.
|
Genta, R. M.,
C. L. Chappell,
A. C. White,
K. T. Kimball, and R. W. Goodgame.
1993.
Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis.
Gastroenterology
105:1769-1775[Medline].
|
| 8.
|
Guarino, A.,
R. B. Canani,
A. Casola,
E. Pozio,
R. Russo,
E. Bruzzese,
M. Fontana, and A. Rubino.
1995.
Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells.
J. Infect. Dis.
171:976-983[Medline].
|
| 9.
|
Hill, B. D.,
D. A. Blewett,
A. M. Dawson, and S. Wright.
1991.
Cryptosporidium parvum: investigation of sporozoite excystation in vivo and the association of merozoites with intestinal mucus.
Res. Vet. Sci.
51:264-267[Medline].
|
| 10.
|
Jung, H. C.,
L. Eckmann,
S. K. Yang,
A. Panja,
J. Fierer,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1995.
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
J. Clin. Invest.
95:55-65.
|
| 11.
|
Knudsen, P. J.,
C. A. Dinarello, and T. B. Strom.
1986.
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.
J. Immunol.
137:3189-3194[Abstract].
|
| 12.
|
Laurent, F.,
L. Eckmann,
T. C. Savidge,
G. Morgan,
C. Theodos,
M. Naciri, and M. F. Kagnoff.
1997.
Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines.
Infect. Immun.
65:5067-5073[Abstract].
|
| 13.
|
Lawson, L. D., and D. W. Powell.
1987.
Bradykinin-stimulated eicosanoid synthesis and secretion by rabbit ileal components.
Am. J. Physiol.
252:G783-G790[Abstract/Free Full Text].
|
| 14.
|
Lefkowitch, J. H.,
S. Krumholz,
K. C. Feng-Chen,
P. Griffin,
D. Despommier, and T. A. Brasitus.
1984.
Cryptosporidiosis of the human small intestine: a light and electron microscopic study.
Hum. Pathol.
15:746-752[Medline].
|
| 15.
|
Marcial, M. A., and J. L. Madara.
1986.
Cryptosporidium: cellular localization, structural analysis of absorptive cell-parasite membrane-membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells.
Gastroenterology
90:583-594[Medline].
|
| 16.
|
McCool, D. J.,
M. A. Marcon,
J. F. Forstner, and G. G. Forstner.
1990.
The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues.
Biochem. J.
267:491-500[Medline].
|
| 17.
|
Meisel, J. L.,
D. R. Perera,
C. Meligro, and C. E. Rubin.
1976.
Overwhelming watery diarrhea associated with a Cryptosporidium in an immunosuppressed patient.
Gastroenterology
70:1156-1160[Medline].
|
| 18.
|
Modigliani, R.,
C. Bories,
Y. Le Charpentier,
M. Salmeron,
B. Messing,
A. Galian,
J. C. Rambaud,
A. Lavergne,
B. Cochand-Priollet, and I. Desportes.
1985.
Diarrhoea and malabsorption in acquired immune deficiency syndrome: a study of four cases with special emphasis on opportunistic protozoan infestations.
Gut
26:179-187[Abstract/Free Full Text].
|
| 19.
|
Savidge, T. C.,
A. L. Morey,
D. J. Ferguson,
K. A. Fleming,
A. N. Shmakov, and A. D. Phillips.
1995.
Human intestinal development in a severe-combined immunodeficient xenograft model.
Differentiation
58:361-371[Medline].
|
| 20.
|
Sears, C. L., and R. L. Guerrant.
1994.
Cryptosporidiosis: the complexity of intestinal pathophysiology.
Gastroenterology
106:252-254[Medline].
|
| 21.
|
Selik, R. M.,
S. Y. Chu, and J. W. Ward.
1995.
Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.
Ann. Intern. Med.
123:933-936[Abstract/Free Full Text].
|
| 22.
|
Thea, D. M.,
M. E. Pereira,
D. Kotler,
C. R. Sterling, and G. T. Keusch.
1992.
Identification and partial purification of a lectin on the surface of the sporozoite of Cryptosporidium parvum.
J. Parasitol.
78:886-893[Medline].
|
| 23.
|
Thulin, J. D.,
M. S. Kuhlenschmidt,
M. D. Rolsma,
W. L. Current, and H. B. Gelberg.
1994.
An intestinal xenograft model for Cryptosporidium parvum infection.
Infect. Immun.
62:329-331[Abstract/Free Full Text].
|
| 24.
|
Upton, S. J.,
M. Tilley, and D. B. Brillhart.
1995.
Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells.
J. Clin. Microbiol.
33:371-375[Abstract].
|
| 25.
|
Williams, C. S., and R. N. DuBois.
1996.
Prostaglandin endoperoxide synthase: why two isoforms?
Am. J. Physiol.
270:G393-G400[Abstract/Free Full Text].
|
Infect Immun, April 1998, p. 1787-1790, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pantenburg, B., Dann, S. M., Wang, H.-C., Robinson, P., Castellanos-Gonzalez, A., Lewis, D. E., White, A. C. Jr.
(2008). Intestinal Immune Response to Human Cryptosporidium sp. Infection. Infect. Immun.
76: 23-29
[Full Text]
-
Gookin, J. L., Duckett, L. L., Armstrong, M. U., Stauffer, S. H., Finnegan, C. P., Murtaugh, M. P., Argenzio, R. A.
(2004). Nitric oxide synthase stimulates prostaglandin synthesis and barrier function in C. parvum-infected porcine ileum. Am. J. Physiol. Gastrointest. Liver Physiol.
287: G571-G581
[Abstract]
[Full Text]
-
Zaalouk, T. K., Bajaj-Elliott, M., George, J. T., McDonald, V.
(2004). Differential Regulation of {beta}-Defensin Gene Expression during Cryptosporidium parvum Infection. Infect. Immun.
72: 2772-2779
[Abstract]
[Full Text]
-
Berkes, J, Viswanathan, V K, Savkovic, S D, Hecht, G
(2003). Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut
52: 439-451
[Abstract]
[Full Text]
-
Cole, J., Blikslager, A., Hunt, E., Gookin, J., Argenzio, R.
(2003). Cyclooxygenase blockade and exogenous glutamine enhance sodium absorption in infected bovine ileum. Am. J. Physiol. Gastrointest. Liver Physiol.
284: G516-G524
[Abstract]
[Full Text]
-
Chen, X.-M., Keithly, J. S., Paya, C. V., LaRusso, N. F.
(2002). Cryptosporidiosis. NEJM
346: 1723-1731
[Full Text]
-
Blikslager, A., Hunt, E., Guerrant, R., Rhoads, M., Argenzio, R.
(2001). Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis. Am. J. Physiol. Gastrointest. Liver Physiol.
281: G645-G653
[Abstract]
[Full Text]
-
Stenson, W. F., Zhang, Z., Riehl, T., Stanley, S. L. Jr.
(2001). Amebic Infection in the Human Colon Induces Cyclooxygenase-2. Infect. Immun.
69: 3382-3388
[Abstract]
[Full Text]
-
Laurent, F., Mancassola, R., Lacroix, S., Menezes, R., Naciri, M.
(2001). Analysis of Chicken Mucosal Immune Response to Eimeria tenella and Eimeria maxima Infection by Quantitative Reverse Transcription-PCR. Infect. Immun.
69: 2527-2534
[Abstract]
[Full Text]
-
Robinson, P., Okhuysen, P. C., Chappell, C. L., Lewis, D. E., Shahab, I., Janecki, A., White, A. C. Jr.
(2001). Expression of Tumor Necrosis Factor Alpha and Interleukin 1{beta} in Jejuna of Volunteers after Experimental Challenge with Cryptosporidium parvum Correlates with Exposure but Not with Symptoms. Infect. Immun.
69: 1172-1174
[Abstract]
[Full Text]
-
Kasper, L. H., Buzoni-Gatel, D.
(2001). Ups and Downs of Mucosal Cellular Immunity against Protozoan Parasites. Infect. Immun.
69: 1-8
[Full Text]
-
McCole, D. F., Eckmann, L., Laurent, F., Kagnoff, M. F.
(2000). Intestinal Epithelial Cell Apoptosis following Cryptosporidium parvum Infection. Infect. Immun.
68: 1710-1713
[Abstract]
[Full Text]
-
O'Neil, D. A., Porter, E. M., Elewaut, D., Anderson, G. M., Eckmann, L., Ganz, T., Kagnoff, M. F.
(1999). Expression and Regulation of the Human {beta}-Defensins hBD-1 and hBD-2 in Intestinal Epithelium. J. Immunol.
163: 6718-6724
[Abstract]
[Full Text]
-
Clark, D. P.
(1999). New Insights into Human Cryptosporidiosis. Clin. Microbiol. Rev.
12: 554-563
[Abstract]
[Full Text]